B-cell Chronic Lymphocytic Leukemia in Relapse
📧 Sign up to get email alerts when something new happens for B-cell Chronic Lymphocytic Leukemia in Relapse.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluating a combination of ibrutinib, obinutuzumab, and venetoclax in patients with B-cell chronic lymphocytic leukemia, in…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tandem CAR T cells targeting CD19 and CD22 for relapsed or chemotherapy-refractory B-cell malignancies.